(3beta,23R)-14,15,16,17-Tetradehydroveratraman-3,23-diol(CAS: 60-70-8)

The compound (3beta,23R)-14,15,16,17-Tetradehydroveratraman-3,23-diol (CAS: 60-70-8) falls under the scope of various regulatory guidelines including GHS classification for hazardous chemicals, REACH regulations for European Union-based manufacturers, and FDA/EPA requirements for safety and environmental impact assessments. Compliance with these guidelines ensures safe handling, storage, and disposal of the compound.

Alternatives to (3beta,23R)-14,15,16,17-Tetradehydroveratraman-3,23-diol (CAS: 60-70-8) in synthesis include using isomers or analogs like (3alpha,23R)-14,15,16,17-tetradehydroveratraman-3,23-diol, or employing substitute reagents such as 14,15,16,17-tetradehydroveratraldehyde. These alternatives offer similar functionalities but with different structural properties.

The market for (3beta,23R)-14,15,16,17-Tetradehydroveratraman-3,23-diol (CAS: 60-70-8) is characterized by increasing research interest in its potential applications in pharmaceuticals and natural product chemistry. Recent trends indicate growing exploration of its structural and biological properties, driven by its unique chemical characteristics and potential in new drug discovery.

Waste containing (3beta,23R)-14,15,16,17-Tetradehydroveratraman-3,23-diol (CAS: 60-70-8) should be collected and disposed of in accordance with local and international regulations. Proper incineration or professional waste disposal services are recommended. Precautions include ensuring safe containment during handling and disposal to prevent environmental contamination, and compliance with all relevant regulatory requirements.